Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Juniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference
-
Iroko Pharmaceuticals Secures Debt Financing From CRG
-
Dimension Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
-
DURECT to Present at the Cantor Fitzgerald Healthcare Conference
-
Nicox added to Russell Global Index
-
Sprott Enhances Flexibility for Accretive Growth for the Physical Silver and Physical Platinum and Palladium Trusts
-
Cyclacel Pharma (CYCC) Enters $4M At Market Issuance Sales Agreement
-
Eiger BioPharmaceuticals (EIGR) Enters $25M Stock Sales Agreement
-
Agile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Cantor Fitzgerald Starts Sabra Healthcare REIT Inc. (SBRA) at Buy
-
Cantor Fitzgerald Starts Healthcare Realty Trust (HR) at Hold
-
Cantor Fitzgerald Starts LTC Properties (LTC) at Buy
-
Cantor Fitzgerald Starts National Health Investors (NHI) at Hold
-
Cantor Fitzgerald Starts Physicians Realty Trust (DOC) at Buy
-
Luminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference
-
ScienceLogic CEO Dave Link Named Ernst & Young Entrepreneur Of The Year(R) 2016 Mid-Atlantic Award Winner
-
Cross Country Healthcare to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
U.S. FDA grants Priority Review for Nicox's AC-170 New Drug Application
-
Conyers Park Acquisition Corp. Files Registration Statement for Initial Public Offering of Securities
-
Cantor Fitzgerald is Positive on Relypsa (RLYP) as Outpatient Prescriptions Grow Another 30+%
-
Hooper Holmes to Present at the Cantor Fitzgerald Healthcare Conference
-
Kew Media Group Inc. Announces Completion of $70,000,000 Initial Public Offering
-
Orchid Island Capital Announces June 2016 Monthly Dividend and May 31, 2016 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Alcobra Ltd. (ADHD) at Buy
-
Kew Media Group Inc. Files Final Prospectus for Initial Public Offering of $70,000,000 of Class a Restricted Voting Units
-
Notable Analyst Rating Changes 6/3: (UNP) (DE) (WFT) Upgraded; (ICLR) (TSL) (PCAR) Downgraded
-
Pre-Open Stock Movers 06/03: (TLN) (IMMU) (AMBA) Higher; (WRES) (ONTY) (ZUMZ) Lower (more...)
-
Cantor Fitzgerald Starts Dimension Therapeutics (DMTX) at Buy
-
After-Hours Stock Movers 06/02: (AMBA) (BV) (AVGO) Higher; (WRES) (ZUMZ) (CC) Lower (more...)
-
Cantor Fitzgerald Starts Spark Therapeutics (ONCE) at Buy
-
Cantor Fitzgerald Starts Aerie Pharma (AERI) at Buy
-
Cantor Fitzgerald Starts Omeros Corp. (OMER) at Buy
-
Cantor Fitzgerald Starts GW Pharma (GWPH) at Buy
-
Cantor Fitzgerald Starts bluebird bio (BLUE) at Hold
-
Cantor Fitzgerald Starts Glaukos Corporation (GKOS) at Buy
-
Notable Analyst Rating Changes 6/2: (SBH) (WCN) (PSTG) Upgraded; (BEN) (PGR) (XOM) Downgraded
-
Pre-Open Stock Movers 06/02: (BWEN) (RPRX) (CIEN) Higher; (CONN) (SRPT) (DV) Lower (more...)
-
Cantor Fitzgerald Upgrades Tonix Pharma (TNXP) to Buy
-
Notable Analyst Rating Changes 5/27: (CAL) (VSLR) (NUVA) Upgraded; (WDAY) (SIG) (AAPL) Downgraded
-
Cantor Fitzgerald Upgrades Synergy Resources Corporation (SYRG) to Buy
-
Celldex (CLDX) Enters Controlled Equity Sales Agreement
-
Oncobiologics Announces Closing of Initial Public Offering of Units
-
Relypsa's (RLYP) Veltassa Still in its Early Going - Cantor Fitzgerald
-
College Ave Student Loans to Present on Student Loans and Online Lending Marketplace Trends at May Conferences
-
Supply disruptions boost oil; stocks rise
-
Oncobiologics Announces Pricing of Its Initial Public Offering of Units
-
GlobeImmune Announces Updates and Financial Results for First Quarter 2016
-
Orchid Island Capital Announces May 2016 Monthly Dividend and April 29, 2016 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Downgrades BioDelivery Sciences International (BDSI) to Hold
-
Rambler Completes Its 13th Shipment of High Grade Copper Concentrate


